Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €4.59 EUR
Change Today +0.03 / 0.66%
Volume 29.7K
MKEA On Other Exchanges
Symbol
Exchange
EN Paris
As of 11:35 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

mauna kea technologies (MKEA) Snapshot

Open
€4.55
Previous Close
€4.56
Day High
€4.64
Day Low
€4.55
52 Week High
04/28/14 - €12.10
52 Week Low
04/15/15 - €4.51
Market Cap
65.2M
Average Volume 10 Days
78.8K
EPS TTM
--
Shares Outstanding
14.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MAUNA KEA TECHNOLOGIES (MKEA)

Related News

No related news articles were found.

mauna kea technologies (MKEA) Related Businessweek News

No Related Businessweek News Found

mauna kea technologies (MKEA) Details

Mauna Kea Technologies S.A. engages in the design, development, and manufacture of medical devices for medical imaging. The company offers Cellvizio, a probe-based Confocal Laser Endomicroscopy solution that performs microscopic imaging. Its Cellvizio platform provides various Confocal Miniprobes to answer the specific needs of each endoscopy field comprising GastroFlex for Eso-Gastro-Duodenoscopy; CholangioFlex for Confocal Cholangioscopy in ERCP; ColoFlex for Colonoscopy; and AlveoFlex for Bronchoscopy and Alveoscopy. The company is also involved in the development of pre-clinical research systems, including ProFlex microprobes; Laser Scanning Unit, a high-resolution fibered confocal microscope; and ImageCell software that quantifies data in real time for various applications, such as deep brain imaging, Angiogenesis, peripheral nervous system, GI cancer research, stem cells, and pancreatic cancer imaging. It primarily serves the gastroenterologists and pulmonologists. The company was founded in 2000 and is based in Paris, France.

120 Employees
Last Reported Date: 04/14/15
Founded in 2000

mauna kea technologies (MKEA) Top Compensated Officers

Founder, Chief Executive Officer and Director
Total Annual Compensation: €270.0K
Compensation as of Fiscal Year 2013.

mauna kea technologies (MKEA) Key Developments

Mauna Kea Technologies Obtains Regulatory Approval for the Commercialization of Cellvizio® in Mexico

Mauna Kea Technologies announced it has received regulatory approval from COFEPRIS (Comisión Federal Para la Protección contra Riesgos Sanitarios), the Mexican health authority, for the commercialization of Cellvizio in a country that of 122 million people. Mauna Kea Technologies is now able to implement its marketing strategy with its partner, Endomédica.

Mauna Kea Technologies SAS Announces Earnings Results for the Full Year Ended December 31, 2014; Announces Sales Results for the First Quarter Ended March 31, 2015

Mauna Kea Technologies SAS announced earnings results for the full year ended December 31, 2014. For the year, the company announced total revenue of EUR 12,282,000 compared to EUR 10,915,000 for the same period a year ago. Operating loss was EUR 13,823,000 compared to EUR 11,521,000 for the same period a year ago. Net loss was EUR 13,991,000 compared to EUR 11,516,000 for the same period a year ago. The company announced sales results for the first quarter ended March 31, 2015. For the quarter, the company announced sales of EUR 1,855,000 compared to EUR 2,164,000 for the same period a year ago.

Mauna Kea Technologies SAS, Board Meeting, Apr 13, 2015

Mauna Kea Technologies SAS, Board Meeting, Apr 13, 2015. Agenda: To consider annual results for the financial year ended on December 31, 2014 and sales for the 1st quarter of the financial year, ended on March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MKEA:FP €4.59 EUR +0.03

MKEA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.85 USD 0.00
MELA Sciences Inc $1.45 USD +0.01
Optiscan Imaging Ltd A$0.06 AUD +0.001
Verisante Technology Inc C$0.10 CAD 0.00
View Industry Companies
 

Industry Analysis

MKEA

Industry Average

Valuation MKEA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.7x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAUNA KEA TECHNOLOGIES, please visit www.maunakeatech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.